期刊文献+

前列腺癌MR灌注成像与肿瘤血管生成相关性研究 被引量:14

MR Perfusion-weighted Imaging of Prostatic Cancer:Correlation with Tumor Angiogenesis
下载PDF
导出
摘要 目的 探讨MR灌注成像在前列腺癌中的应用 ,评价血管内皮生长因子 (VEGF)和微血管密度 (MVD)与MR灌注成像各指标的相关关系。资料与方法 对临床诊断为前列腺癌的 15例患者和 30名健康志愿者进行MR灌注成像 ,对前列腺癌标本进行免疫组织化学检测 ;分析病变的灌注曲线最大线性斜率 (SSmax)、T2 弛豫率 (ΔR2 peak)与免疫组织化学结果 (VEGF、MVD)的各自相关性。结果  (1)健康志愿者灌注曲线的SSmax及ΔR2 peak分别为 :0 .4 30± 0 .0 11,2 .0 1± 0 .0 7;前列腺癌灌注曲线的SSmax及ΔR2 peak分别为 :5 7.8± 5 .0 ,3.0± 0 .6 ,两者之间存在显著性差异 (P <0 .0 1)。 (2 )前列腺癌的VEGF和MVD的表达水平明显升高。结论 灌注成像的有关指标(SSmax、ΔR2 peak)可以反映前列腺癌MVD和VEGF表达的高低 ,从而推测其血管生成情况 。 Objective To evaluate MR perfusion-weighted imaging (PWI) in the diagnosis of prostatic cancer, to discuss the correlation of PWI features with vascular endothelial growth factor (VEGF) and microvessel density (MVD). Materials and Methods MR PWI was performed in consecutive 15 patients with clinically-diagnosed prostatic cancer (study group) and 30 healthy volunteers (control group). The maximum steepest slope of signal intensity-time curve (SSmax) and the ΔR 2 * peak of the lesions were measured. VEGF and MVD of the specimen were estimated with immuno-histochemistry technique. The correlation of SSmax and ΔR 2 * peak with VEGF and MVD was individually analyzed.Results (1) The SSmax and ΔR 2 * peak were 0.430±0.011 and 2.01±0.07 in the control group, and were 57.8±5.0 and 3.0±0.6 in the study group, respectively, with significant difference between the two groups (t=4.11 and 3.28, P<0.01). (2) VEGF and MVD expression in the study group was markedly higher.Conclusion Both SSmax and ΔR 2 * peak can reflect the expression level of VEGF and MVD in prostatic cancer, based on which the tumor angiogenesis can be inferred, providing surgeon with important diagnostic information.
出处 《临床放射学杂志》 CSCD 北大核心 2004年第6期485-488,共4页 Journal of Clinical Radiology
关键词 前列腺癌 MR灌注成像 肿瘤血管生成 相关性研究 微血管密度 血管内皮生长因子 Prostatic cancer Magnetic resonance imaging Perfusion
  • 相关文献

参考文献12

  • 1Kucharczyk J,Roberts T,Moseley EE,et al. Contrast-enhanced perfusion-sensitive MR imaging in the diagnosis of cerebrovascular disorders. Magn Reson Imaging,1993,3:241
  • 2Villringer A,Rosen BR,Belliveau JW,et al. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med,1988,6:164
  • 3Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol,1995,147:9
  • 4Mattern J,Koomagi R,Volm M. Vascular endothelial growth factor expression and angiogenesis in non-small cell lung carcinomas. Int J Cancer,1995,6:1059
  • 5Verstraete KL,De Deene Y,Roels H,et al.Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging-parametric "first-pass" imaging depict tissue vascularization and perfusion. Radiology,1994,192:835
  • 6张龙江 ,包颜明 ,祁吉 .对比剂首过MR灌注成像在脑胶质瘤中的应用价值[J].中国医学影像技术,2004,20(5):810-813. 被引量:23
  • 7王建利,谢敬霞.对比增强磁共振脑血流灌注成像[J].临床放射学杂志,2000,19(3):184-188. 被引量:8
  • 8Kuhl CK,Bieling H,Gieseke J,et al. Breast neoplasms: T2* susceptibility-contrast,first-pass perfusion MR imaging. Radiology,1997,202:87
  • 9韩鸿宾,谢敬霞.磁共振顺磁性对比剂脑灌注成像的研究[J].中华放射学杂志,1999,33(7):457-462. 被引量:14
  • 10Wilke N,Simm C,Zhang J,et al. Contrast-enhanced first pass myocardial perfusion imaging: correlation between myocardial blood flow in dogs at rest and during hyperemia. Magn Reson Med,1993,29:485

二级参考文献30

  • 1[1]Villringer A,Rosen BR,Belliveau JW,et al.Dynamic imaging with lanthanide chelates in normal brain:contrast due to magnetic susceptibility effects[J].Magn Reson Med,1998,6(2):164-174.
  • 2[2]Cha S,Knopp EA,Johnson CT,et al.Dynamic contrast-enhamed T2*-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin[J].AJNR,2000,21(5):881-890.
  • 3[3]Cha S,Knopp EA,Johnson CT,et al.Intracranial mass lesions:dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging[J].Radiology,2002,223(1):11-29.
  • 4[4]Knopp EA,Cha S,Johnson CT,et al.Glial neoplasms:dynamic contrast-enhanced T2*-weighted MR imaging[J].Radiology,1999,211(3):791-798.
  • 5[5]Jezzard P.Advances in perfusion MR imaging[J].Radiology,1998,208(1):296-299.
  • 6[6]Petrella JR,Provenzale JM.MR perfusion imaging of the brain:techniques and applications[J].AJR,2000,175(1):207-219.
  • 7[7]Shin JH,Lee HK,Kwun BD,et al.Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas:preliminary results[J].AJR,2002,179(3):783-789.
  • 8[8]Sugahara T,Korogi Y,Kochi M,et al.Perfusion-sensitive MR imaging of gliomas:comparison between gradient-echo and spin-echo echo-planar imaging technique[J].AJNR,2001,22(8):1306-1315.
  • 9[9]Cho SK,Na DG,Ryoo JW,et al.Perfusion MR imaging:clinical utility for the differential diagnosis of various brain tumors[J].Korean J Radiology,2002,3(3):171-179.
  • 10[10]Lee SJ,Kim JH,Kim YM,et al.Perfusion MR imaging in gliomas:Comparison with histologic tumor grade[J].Korean J Radiology,2001,2(1):1-7.

共引文献86

同被引文献193

引证文献14

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部